Hamburg To Advise Institute of Medicine On International Issues
This article was originally published in The Gray Sheet
Executive Summary
Having shepherded FDA through hurdles resulting from globalization, the now-former FDA Commissioner Hamburg will advise IOM on international issues that affect the U.S. healthcare system as IOM's newly appointed foreign secretary.
You may also be interested in...
FDA Staying The Course Under Ostroff; Hamburg’s Concerns Will Remain Focus
Acting FDA Commissioner says he can’t envision any new major priorities that would emerge in the short-term.
Hamburg: Neither U.S. Nor EU Device Regulation Has It Completely Right
During her final public appearance at the National Press Club, outgoing FDA Commissioner Margaret Hamburg defended her tenure and said she was leaving a stronger FDA than the one she inherited. Asked about the agency's device regulatory process, she said she didn't know if FDA or Europe had struck the right balance but said more work needs to be done.
Big Pharma BD Execs Tell Start-Ups: Don’t Be Afraid To Ask Us For Help
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: